BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Delcath Systems, Inc. Resumes Enrollment in Phase III and Phase II Trials

  November 20, 2007

   · 

  1 min read
• Business

  Smiths Medical, Inc., Premier, Inc. Sign 3-Year Contract

  November 20, 2007

   · 

  1 min read
• Drug Development

  Array BioPharma, Inc. Advances p38 Inhibitor, ARRY-797, into Phase 2 Clinical Trial

  November 20, 2007

   · 

  1 min read
• Pharm Country

  Morphotek Inc.'s Research Uncovers Molecular Function of Endosialin Target of MORAb-004, Anti-Angiogenic Antibody Being Evaluated for Cancer, Neovascular Disease

  November 20, 2007

   · 

  1 min read
• Business

  LifeCycle Pharma to Host Third Quarter 2007 Financial Results Conference Call and Webcast

  November 20, 2007

   · 

  1 min read
• Biotech Bay

  NovaBay Pharmaceuticals, Inc. (formerly known as NovaCal Pharmaceuticals, Inc.) Featured In November/December Issue of PharmaVOICE

  November 20, 2007

   · 

  1 min read
• Pharm Country

  Acorda Therapeutics to Present at Two Upcoming Conferences

  November 20, 2007

   · 

  1 min read
• Business

  MIT Holding Inc. Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2007

  November 20, 2007

   · 

  1 min read
• BioCapital

  Avalon Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference

  November 20, 2007

   · 

  1 min read
• Pharm Country

  Lux Biosciences to Present at Upcoming Investor Conferences

  November 20, 2007

   · 

  1 min read